Trident Lifeline (TLL) Share Price: TLL trades at Rs 425 near peak zone
- October 21, 2026
- Posted by: Chaitanya Auti
- Category: News
Trident Lifeline Share Price is Rs 425, up 5.72%, and trading near its peak zone as of 21 October 2026 at 9:24:55 AM IST. The company’s market capitalisation stands at Rs 481.64 crore, and the latest Univest data confirms the price event without establishing a company-specific trigger.
Trident Lifeline Share Price is trading at Rs 425, up 5.72% from the previous close of Rs 402, with the stock placed near its peak zone and a market capitalisation of Rs 481.64 crore. Trident Lifeline Share Price Today therefore stands out in Stocks in News and Stock Market Today, although the latest Univest data does not establish a company-specific catalyst. For readers tracking Trident Lifeline Stock News, the move is notable because the price, valuation and sector context can now be read together. Trident Lifeline Share Price remains an event-led story for those following Trident Lifeline Share Price Today, Trident Lifeline Stock News and Trident Lifeline Share News across the Indian stock market.
Trident Lifeline Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 425 |
| Previous Close | Rs 402 |
| Today's Move | +Rs 23 (+5.72%) |
| Open | Rs 425 |
| High | Rs 425 |
| Low | Rs 425 |
| Market Capitalisation | Rs 481.64 crore |
Trident Lifeline Ltd. (TLL) traded at Rs 425 versus the previous close of Rs 402, a rise of 5.72%. The stock opened at Rs 425, reached a high of Rs 425 and touched a low of Rs 425.
Trident Lifeline Share Price Today opened at Rs 425 and stayed at the same level through the displayed range, with the day high and day low both at Rs 425. Compared with the previous close of Rs 402, the stock is higher by Rs 23, or 5.72%. That places Trident Lifeline Share Price in a strong intraday position for the period covered by the latest Univest figures, while still remaining a near-peak stock rather than a session-end statement. Trident Lifeline Share Price Live readers will note that the opening price matched the recorded high and low, which makes the move easy to read from the available print. On current facts alone, the latest Trident Lifeline Share Price Update is a clean upward gap from the prior reference point, and the next section turns to the fundamental profile behind Trident Lifeline Stock News.
Trident Lifeline Ltd. (TLL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 481.64 crore |
| P/E Ratio | 25.29x |
| P/B Ratio | 4.86x |
| ROE | 18.78% |
| ROCE | 19.17% |
| EPS | Rs 15.89 |
| Book Value Per Share | Rs 82.76 |
| Dividend Yield | 0% |
Trident Lifeline Ltd. (TLL) fundamental metrics show P/E 25.29x, P/B 4.86x, ROE 18.78%, ROCE 19.17%. These figures provide context only and are not a buy or sell signal.
Trident Lifeline Ltd. has a market capitalisation of Rs 481.64 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.29x, P/B at 4.86x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.78% and ROCE of 19.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.89, book value per share of Rs 82.76, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.73x, median ROE of 11.33%, median ROCE of 13.25%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 25.29x |
| Benchmark Median P/E | 31.73x |
| Benchmark Average P/E | 45.98x |
| Benchmark P/E Range | 3.1x to 616.89x |
| Company P/B Ratio | 4.86x |
| Benchmark Median P/B | 2.76x |
| Company ROE | 18.78% |
| Benchmark Median ROE | 11.33% |
| Company ROCE | 19.17% |
| Benchmark Median ROCE | 13.25% |
| Company Market Capitalisation | Rs 481.64 crore |
| Benchmark Median Market Cap | Rs 771.43 crore |
Trident Lifeline Ltd. (TLL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Trident Lifeline Ltd. (TLL) has a P/E ratio of 25.29x, which is below the benchmark median of 31.73x, a difference of -20.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Trident Lifeline Ltd. (TLL) has a ROE of 18.78%, which is above the benchmark median of 11.33%, a difference of +65.75%. Trident Lifeline Ltd. (TLL) has a ROCE of 19.17%, which is above the benchmark median of 13.25%, a difference of +44.68%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,18,683.95 | 34.61 | 4.84 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,41,310.94 | 82.5 | 13.66 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,73,078.79 | 79.36 | 19.28 | 26.76 | 19.27 |
| Laurus Labs Ltd. | LAURUSLABS | 1,11,433.99 | 101.92 | 19.76 | 18.31 | 18.2 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,022.18 | 24.6 | 4.12 | 19.69 | 21.39 |
Trident Lifeline Ltd. (TLL) has a P/E ratio of 25.29x compared with the displayed peer median of 79.36x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.78% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 19.17% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Trident Lifeline Ltd. (TLL) has a market capitalisation of Rs 481.64 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Trident Lifeline
- Trident Lifeline Share Price is at Rs 425, up 5.72% from the previous close of Rs 402.
- The stock is trading near its peak zone in the latest Univest reading.
- Market capitalisation stands at Rs 481.64 crore.
- P/E is 25.29, below the healthcare industry median of 31.73.
- ROE is 18.78% and ROCE is 19.17%, both above the industry medians.
About Trident Lifeline
Trident Lifeline Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. In this Stock Analysis, the company is being tracked through its listed market price, market capitalisation and financial ratios rather than through narrative assumptions. For readers following Trident Lifeline Company News, the key reference points are its valuation multiples, return ratios and position against listed peers. Trident Lifeline Share Price today is therefore best understood as part of a broader Market Update on a healthcare name that is being compared with other listed pharmaceutical companies.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Trident Lifeline Share Price up today?
Ans. Trident Lifeline Share Price is up 5.72% to Rs 425 from Rs 402. The latest Univest data confirms the price move, but it does not identify a company-specific reason for the advance.
What is Trident Lifeline Share Price today?
Ans. Trident Lifeline Share Price today is Rs 425. The stock is also being tracked near its peak zone, with the latest reading showing a rise of Rs 23 over the previous close.
What is the market capitalisation of Trident Lifeline?
Ans. Trident Lifeline has a market capitalisation of Rs 481.64 crore. That places it below the healthcare industry median market capitalisation of Rs 771.43 crore in the same industry benchmark.
How does Trident Lifeline compare on valuation?
Ans. Trident Lifeline Share Price sits with a P/E of 25.29 and P/B of 4.86. The P/E is below the industry median, while the P/B is above the industry median and average.
What do ROE and ROCE show for Trident Lifeline?
Ans. Trident Lifeline reports ROE of 18.78% and ROCE of 19.17%. Both are above the healthcare industry medians of 11.33% and 13.25%, giving useful context to Trident Lifeline Share Price.
What are Trident Lifeline EPS and book value?
Ans. EPS is Rs 15.89 and book value is Rs 82.76. EPS reflects earnings per share, while book value shows accounting net worth per share, both relevant to Trident Lifeline Share Price analysis.
Does Trident Lifeline pay a dividend?
Ans. The dividend yield is 0. That means the current Trident Lifeline Share Price should be read without a dividend yield component in the present market snapshot.
How does Trident Lifeline compare with peers?
Ans. Compared with large healthcare peers such as Sun Pharmaceutical, Divi's Laboratories and Torrent Pharmaceuticals, Trident Lifeline has a much smaller market cap and a lower P/E than several listed peers.
Track Trident Lifeline Share Price on Univest
Use Trident Lifeline Ltd. (TLL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Trident Lifeline Share Price on Univest for live price updates, financial ratios, market capitalisation, sector context and peer comparison. Univest also helps users follow Trident Lifeline Stock News, Trident Lifeline Latest News and Trident Lifeline Share Price Live in one place with structured market insights.